| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 5 |
| 1 | LAMIVUDINE ORAL | 5 |
| 2 | ABACAVIR | 3 |
| 3 | ABACAVIR SULFATE | 3 |
| 4 | BULEVIRTIDE | 3 |
| 5 | SOFOSBUVIR | 3 |
| 6 | TENOFOVIR DISOPROXIL FUMARATE | 3 |
| 7 | CYCLOPHOSPHAMIDE | 2 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BULEVIRTIDE | 3 | 0.0312 |
| 1 | AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE | 1 | 0.0008 |
| 2 | ABACAVIR SULFATE | 3 | 0.0003 |
| 3 | LAMIVUDINE | 5 | 0.0002 |
| 4 | SOFOSBUVIR | 3 | 0.0002 |
| 5 | DOXORUBICIN HYDROCHLORIDE | 2 | 0.0001 |
| 6 | SODIUM BICARBONATE INJECTION, | 1 | 0.0000 |
| 7 | RIBAVIRIN | 2 | 0.0000 |
| 8 | NEBIVOLOL HYDROCHLORIDE | 1 | 0.0000 |
| 9 | DOXORUBICIN | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0001 |
| 1 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0000 |
| 3 | Nucleoside Analog Antiviral [EPC] | 2 | 0.0000 |
| 4 | Thiazide-like Diuretic [EPC] | 1 | 0.0000 |
| 5 | Alkylating Drug [EPC] | 2 | 0.0000 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 2 | 0.0000 |
| 7 | Vitamin D [EPC] | 1 | 0.0000 |
| 8 | Vitamin B12 [EPC] | 1 | 0.0000 |
| 9 | Vitamin C [EPC] | 1 | 0.0000 |